ARAVASC, INC.

Basic Information

1520 SAMEDRA ST
SUNNYVALE, CA, 94087-8122

Company Profile

n/a

Additional Details

Field Value
DUNS: 612223037
Hubzone Owned: N
Socially and Economically Disadvantaged: Y
Woman Owned: Y
Number of Employees: 3


  1. SBIR PHASE I AWARD

    Amount: $200,000.00

    Esophageal cancer is a deadly disease with limited treatment options. In addition to modest effects, toxic chemo-therapy drugs cripple patients with debilitating side-effects. This proposal utilizes a ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. MULTIFUNCTIONAL DRUG-DELIVERY STENT WITH NANOPOROUS COAT

    Amount: $199,999.00

    'The overall long-term objective of this proposal is to develop a loco-regional multi-functional theranostic delivery system (MTDS) to treat lung cancer in patients with focal disease, as an adjunct t ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Drug-eluting Tracheobronchial Stents to treat Obstruction caused by Lung Cancer

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Airways can be obstructed by a variety of diseases resulting in breathing difficulties and compromised quality of life for the patients. Lung cancer is one of the ...

    SBIR Phase I 2007 Department of Health and Human Services
  4. SBIR Phase I: Drug Eluting Stents to Treat Obstructed Tracheo-Bronchial Lumen Due to Lung Cancer

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I research project will demonstrate the feasibility of developing a tracheobronchial drug eluting stent (DES) by coating a biodegradable polymeric ...

    SBIR Phase I 2006 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government